Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators.

N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13.

2.

HISTORICAL RESPONSE RATES OF SOMATOSTATIN ANALOGUES IN THE TREATMENT OF ACROMEGALY: A SYSTEMATIC REVIEW.

Shanik MH, Cao PD, Ludlam WH.

Endocr Pract. 2016 Mar;22(3):350-6. doi: 10.4158/EP15913.RA. Epub 2015 Oct 5. Review.

PMID:
26437217
3.

LIMITATIONS OF CURRENT APPROACHES FOR THE TREATMENT OF ACROMEGALY.

Shanik MH.

Endocr Pract. 2016 Feb;22(2):210-9. doi: 10.4158/EP15825.RA. Epub 2015 Oct 5. Review.

PMID:
26437214
4.

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE; EMPA-REG OUTCOME Investigators.

N Engl J Med. 2015 Nov 26;373(22):2117-28. doi: 10.1056/NEJMoa1504720. Epub 2015 Sep 17.

5.

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.

Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group.

N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8. Erratum in: N Engl J Med. 2015 Aug 6;373(6):586.

6.

Sex and ethnic-origin specific BMI cut points improve prediction of 40-year mortality: the Israel GOH study.

Dankner R, Shanik M, Roth J, Luski A, Lubin F, Chetrit A.

Diabetes Metab Res Rev. 2015 Jul;31(5):530-6. doi: 10.1002/dmrr.2642. Epub 2015 May 12.

PMID:
25689480
7.

Tumors, IGF-2, and hypoglycemia: insights from the clinic, the laboratory, and the historical archive.

Dynkevich Y, Rother KI, Whitford I, Qureshi S, Galiveeti S, Szulc AL, Danoff A, Breen TL, Kaviani N, Shanik MH, Leroith D, Vigneri R, Koch CA, Roth J.

Endocr Rev. 2013 Dec;34(6):798-826. doi: 10.1210/er.2012-1033. Epub 2013 May 13. Review.

PMID:
23671155
8.

Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized, treat-to-target trial with a 26-week extension.

Mathieu C, Hollander P, Miranda-Palma B, Cooper J, Franek E, Russell-Jones D, Larsen J, Tamer SC, Bain SC; NN1250-3770 (BEGIN: Flex T1) Trial Investigators.

J Clin Endocrinol Metab. 2013 Mar;98(3):1154-62. doi: 10.1210/jc.2012-3249. Epub 2013 Feb 7.

9.

Basal state hyperinsulinemia in healthy normoglycemic adults heralds dysglycemia after more than two decades of follow up.

Dankner R, Chetrit A, Shanik MH, Raz I, Roth J.

Diabetes Metab Res Rev. 2012 Oct;28(7):618-24. doi: 10.1002/dmrr.2322.

PMID:
22865584
10.

Effect of elevated basal insulin on cancer incidence and mortality in cancer incident patients: the Israel GOH 29-year follow-up study.

Dankner R, Shanik MH, Keinan-Boker L, Cohen C, Chetrit A.

Diabetes Care. 2012 Jul;35(7):1538-43. doi: 10.2337/dc11-1513. Epub 2012 May 22.

11.

Intensifying insulin therapy with insulin analog premixes: transitioning from basal insulin in type 2 diabetes.

Shanik MH.

Diabetes Technol Ther. 2012 Jun;14(6):533-9. doi: 10.1089/dia.2011.0256. Epub 2012 Feb 24. Review.

PMID:
22364142
12.

Changes in neurohormonal gut peptides following bariatric surgery.

Ochner CN, Gibson C, Shanik M, Goel V, Geliebter A.

Int J Obes (Lond). 2011 Feb;35(2):153-66. doi: 10.1038/ijo.2010.132. Epub 2010 Jul 13. Review.

13.

Basal-state hyperinsulinemia in healthy normoglycemic adults is predictive of type 2 diabetes over a 24-year follow-up: a preliminary report.

Dankner R, Chetrit A, Shanik MH, Raz I, Roth J.

Diabetes Care. 2009 Aug;32(8):1464-6. doi: 10.2337/dc09-0153. Epub 2009 May 12.

14.

Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse?

Shanik MH, Xu Y, Skrha J, Dankner R, Zick Y, Roth J.

Diabetes Care. 2008 Feb;31 Suppl 2:S262-8. doi: 10.2337/dc08-s264. Review.

PMID:
18227495

Supplemental Content

Loading ...
Support Center